RS20050835A - Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions - Google Patents

Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions

Info

Publication number
RS20050835A
RS20050835A YUP-2005/0835A YUP83505A RS20050835A RS 20050835 A RS20050835 A RS 20050835A YU P83505 A YUP83505 A YU P83505A RS 20050835 A RS20050835 A RS 20050835A
Authority
RS
Serbia
Prior art keywords
compositions
preparing
dosage forms
drug release
buccal dosage
Prior art date
Application number
YUP-2005/0835A
Other languages
Serbian (sr)
Inventor
Rajesh JAIN
Kour Chand JINDAL
Sukhjeet Singh
Original Assignee
Panacea Biotec Ltd.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd., filed Critical Panacea Biotec Ltd.,
Publication of RS20050835A publication Critical patent/RS20050835A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Buccal dosage form compositions, preferably of poorly bioavailable drug(s), or drug(s) which undergo extensive presystematic metabolism, are provided. The compositions provide extended release of the drug in the oral cavity, and are preferably in the taste masked form. A process of preparing of such compositions is also provided.
YUP-2005/0835A 2004-01-06 2005-01-05 Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions RS20050835A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN24DE2004 2004-01-06
IN26DE2004 2004-01-06
PCT/IN2005/000003 WO2005065640A1 (en) 2004-01-06 2005-01-05 Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions

Publications (1)

Publication Number Publication Date
RS20050835A true RS20050835A (en) 2007-08-03

Family

ID=34751866

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0835A RS20050835A (en) 2004-01-06 2005-01-05 Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions

Country Status (2)

Country Link
RS (1) RS20050835A (en)
WO (1) WO2005065640A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof
CN100450548C (en) * 2006-12-22 2009-01-14 江苏奥赛康药业有限公司 Oral patches containing pdacrilin resin composition and its preparing method
WO2008155620A1 (en) * 2007-06-20 2008-12-24 Develco Pharma Schweiz Ag Dosage form containing dispersible matrix of sustained release granules
US8133506B2 (en) 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
WO2013056159A1 (en) * 2011-10-13 2013-04-18 Jaleva Pharmaceuticals, Llc Methods and compositions for rapid transbuccal delivery of active agents
EP2906210A4 (en) * 2012-10-12 2016-06-08 Jaleva Pharmaceuticals Llc Method of preparing resin tinctures
EP2925273A4 (en) 2012-11-28 2016-08-31 Jaleva Pharmaceuticals Llc Dual chamber applicator
CN105232502A (en) * 2015-02-10 2016-01-13 万全万特制药江苏有限公司 Orally disintegrating tablet containing polacrilin potassium-fluoxertine hydrochloride compound and preparation method of orally disintegrating tablet
CA2993597A1 (en) * 2015-07-23 2017-01-26 Athena Drug Delivery Solutions Pvt Ltd. Zolpidem composition and process for preparing the same
CN114344241B (en) * 2021-12-15 2024-01-30 悦康药业集团安徽天然制药有限公司 Polyacrylic resin modified adsorption drug carrier and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238072B (en) * 1990-01-19 1993-07-03 Sclavo Spa PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ORAL ADMINISTRATION OF CALCITONIN
IL127956A0 (en) * 1996-07-11 1999-11-30 Farmarc Nederland Bv Inclusion complex containing indole selective serotonin agonist
DE19932603A1 (en) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Multi-layer film containing active substance made of in-situ cross-linked hydrophilic polymers
JP2004532838A (en) * 2001-03-02 2004-10-28 ブリストル−マイヤーズ スクイブ カンパニー Compounds useful as melanocortin receptor modulators and pharmaceutical compositions containing them
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device

Also Published As

Publication number Publication date
WO2005065640A8 (en) 2005-12-08
WO2005065640A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
EP1806149A4 (en) Solid medicinal preparation improved in solubility and stability and process for producing the same
IL195294A (en) Process for producing high purity safinamide or ralfinamide, use thereof in the preparation of medicaments and pharmaceutical formulations containing them
IL220480A0 (en) 1-benzyl-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors , preparation method thereof, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
WO2008002245A3 (en) Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
AP2006003596A0 (en) A pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases.
EP1757273A4 (en) Preparation for oral administration
ZA200704246B (en) Solid medicinal preparation improved in solubility and stability and process for producing the same
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
EP1731139A4 (en) S/o type pharmaceutical preparation and process for producing the same
WO2005018605A3 (en) Novel formulation of ropinirole
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
PL1807156T3 (en) New pharmaceutical formulations useful in the treatment of insomnia
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
RS20050835A (en) Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
HUP0401523A2 (en) Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them
HK1100424A1 (en) Oral preparations and process for production thereof
UA87152C2 (en) Solid pharmaceutical composition containing mirtazapine and method for preparation thereof
HUP0500958A2 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
AU2003284786A8 (en) Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
MXPA05007253A (en) Novel anticonvulsant derivative salts.
HK1083199A1 (en) A pharmaceutical composition for use in the prevention and/or treatment of the oral cavity diseases caused by microorganisms
MD2551G2 (en) Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses